News Muncher - searching for developed

2 months, 4 weeks ago

Eye drop not intended to replace reading glasses, ENTOD pharma clarifies after DCGI suspension

NEW DELHI: Days after India’s drug regulator suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop reduced dependency on reading glasses for those suffering from presbyopia, an age-related vision condition, on Thursday clarified that it is a “therapeutic option, available only by prescription from the registered medical practitioner.” This paper was the …

India Reading Company Eye Drop Drug Rti

1 year, 9 months ago

Drug Developed Using DRDO Technology for Radiological and Nuclear Emergencies Gets DCGI Nod

News 18

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India, the defence ministry said on Tuesday. In a statement, the defence ministry said the drug has been developed by the industry based on the technology of Institute of Nuclear Medicine and Allied Sciences, Delhi. ”The manufacturing and …

India Drug Tdf Dcgi Drdo Radiological And Nuclear Emergencies Formulations Developed

1 year, 9 months ago

Critical drug used during nuclear emergencies developed on DRDO tech gets approval

Deccan Chronicle

New Delhi: A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India, the defence ministry said on Tuesday. In a statement, the defence ministry said the drug has been developed by the industry based on the technology of Institute of Nuclear Medicine and Allied Sciences, Delhi. "The …

Tdf Dcgi Drdo Defence Ministry Drug Developed Nuclear Emergencies

1 year, 9 months ago

Drug developed using DRDO technology gets DCGI approval

Firstpost

New Delhi: A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India, the defence ministry said on Tuesday. In a statement, the defence ministry said the drug has been developed by the industry based on the technology of Institute of Nuclear Medicine and Allied Sciences, Delhi. “The …

India Drug Tdf Dcgi Drdo Technology Gets

2 years, 3 months ago

Explained: As India Unveils SII's CERVAVAC, Know How Cervical Cancer Vaccines Work

ABP News

Pune-based pharmaceutical firm Serum Institute of India will soon launch CERVAVAC, India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer. On June 15, 2022, the DCGI’s Subject Expert Committee recommended the qHPV vaccine developed by the SII for cervical cancer patients belonging to the age group of nine to 26 years. HPV vaccines are important because they could …

India Cancer Vaccines Cervical Cervical Cancer Dcgi Caused

2 years, 5 months ago

DCGI Grants Marketing Authorisation to SII's QHPV Vaccine Against Cervical Cancer

News 18

The Drugs Controller General of India on Tuesday granted market authorisation to Serum Institute of India to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine against cervical cancer, official sources said. Prakash Kumar Singh, director at Serum Institute, had applied to the DCGI seeking market authorisation of qHPV after the phase 2/3 clinical trial was completed with support of the …

India Cancer Singh Vaccine Hpv Cervical Cancer Dcgi

2 years, 5 months ago

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use

India TV News

Highlights GEMCOVAC-19 is the first mRNA vaccine that has been developed in India The company will sell the vaccine under the brand name GEMCOVAC-19 The two-dose vaccine will be administered intramuscularly at 28 days apart India's first indigenously developed mRNA vaccine, GEMCOVAC-19, has been approved for emergency use by the Drug Controller General of India on Tuesday. The vaccine has …

India Pune Vaccine Dcgi Emergency Use Developed Mrna Gennova Biopharmaceuticals

2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

India Children Age Vaccine Dcgi Bharat Biotech Covaxin

2 years, 9 months ago

Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI

Firstpost

The company has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity New Delhi: Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India’s first mRNA COVID vaccine to the regulator Drugs Controller General of India on Friday, said sources. “India is heading towards becoming a vaccine superpower and the fact …

India Covid Vaccine Mrna Other Diseases Gennova Biopharmaceuticals

2 years, 9 months ago

DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group

News 18

India’s central drug regulator on Wednesday granted emergency use authorisation to Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 age group subject to certain conditions. Confirming the DCGI approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted:"@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults …

India Emergency Age Group Vaccine Dcgi Emergency Use

2 years, 10 months ago

Bharat Biotech's intranasal COVID booster dose gets DGCI nod for phase 3 trials

Firstpost

An intranasal vaccine would not only be simple to administer but also reduce the use of needles, the Covaxin-maker said. ‘BBV154’ is a replication-deficient adenovirus SARS-CoV-2 vectored vaccine New Delhi/Hyderabad: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with …

India Phase Bharat Vaccine Dcgi Bharat Biotech Clinical Trial

3 years, 2 months ago

Bharat Biotech submits data to DCGI for Covaxin for children in 2-18 age group | Exclusive

India Today

Bharat Biotech, the manufacturer of indigenously developed Covid-19 vaccine Covaxin, has submitted the trial data for children in the 2-18 years age group to the Drugs and Comptroller General of India, the company’s chairman and managing director Dr Krishna Ella told India Today on Saturday. Bharat Biotech completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of …

India Bharat Dcgi Bharat Biotech Biotech Covaxin Krishna Ella

3 years, 4 months ago

Proposal to study mixing of Covaxin, Covishield approved by DCGI

India TV News

The Drugs Controller General Of India, India's drug regulator, has approved a proposal for a study to be conducted on the mixing of two COVID-19 vaccines -- Covishield and Covaxin. The aim of the study will be to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- …

India Medical Research Study Vaccine Dcgi Research Icmr Covaxin

3 years, 6 months ago

Faster & Cheaper Algorithm-based Covid-19 Testing Tool Gets DCGI Nod, Here's How It Works

News 18

Bengaluru-based tech startup Algorithmic Biologics has received regulatory approvals to launch its Covid-19 testing tool that can help scale up testing for the deadly virus infection at half the prevailing cost and one-tenth of the time. Here’s how the Covid-19 testing method works: Quantitative Pooling Algorithm with Gold-standard RT-PCR Test It enables the safe reopening of places of work and …

Bengaluru Testing Iit Algorithm Tapestry Bombay Gets Dcgi

3 years, 6 months ago

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

India TV News

The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India over the weekend, according to government sources. "We have received the data from the phase III trials," a senior government official confirmed. The phase III data of its vaccine have been questioned various times and that …

India Dcgi Covid Vaccine Bharat Biotech Iii Data

3 years, 6 months ago

Zydus Cadila Seeks DCGI Nod for Human Clinical Trials of Antibodies Cocktail to Treat Covid-19

News 18

Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19. “Zydus is currently seeking permission to initiate phase 1/3 human clinical trials from the DCGI… ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies can emerge as one of the main treatments for …

India Treatment Treat Zydus Human Clinical Trials Dcgi Nod Zrc

3 years, 7 months ago

Patanjali had proposed anti-Covid-19 use of a cancer drug one year ago

Op India

On May 8, Defence Research and Development Organisation announced that it got approval for an anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose from the Drugs Controller General of India. Research paper published by Patanjali on 2-DG molecule Before DRDO conducted trials on the drug, scientists and experts from Patanjali Ayurved Ltd, Jain Vishwa Bharti Institute, and Saveetha Institute of Medical …

Cancer Hyderabad Patients Viral Paper Drug Virus

3 years, 7 months ago

DCGI approves anti-COVID drug developed by DRDO for emergency use

India TV News

The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to severe coronavirus patients, the defence ministry said on Saturday. It said clinical trials of the drug 2-deoxy-D-glucose showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. The drug has been …

Drug Drdo Emergency Use

3 years, 7 months ago

Anti-Covid drug developed by DRDO approved for emergency use

India Today

The Drugs Controller General of India has approved the emergency use of drug 2-deoxy-D-glucose as an adjunct therapy in moderate to severe Covid-19 patients. "Clinical trial results have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence. READ: VINS Bioproducts receives DCGI approval to start clinical trials for its Covid-19 treatment candidate In …

India Trial Patients Covid Drug Dcgi Clinical

3 years, 7 months ago

Hetero Biopharma Gets DCGI Expert Panel's Nod for Phase III Trials of Sputnik V

News 18

Hyderabad-based firm Hetero Biopharma has received the permission of Drug Controller General of India’s expert panel to start phase 3 trials for the Russian COVID-19 vaccine Sputnik V in India. In its approval to Hetero Biopharma, the expert panel has asked the firm to study and monitor the vaccine’s immunogenicity on days 21, 24, and 48 of the trial, CNBC-TV18 …

India Trials Biopharma Sec Russian Approval Vaccine

3 years, 7 months ago

VINS Bioproducts receives DCGI approval to start clinical trials for its Covid-19 treatment candidate

India Today

The Drugs Controller General of India, the apex body for clinical trials in India, has given approval to Hyderabad-based immunological company VINS Bioproducts to test its Covid-19 treatment candidate VINCOV-19. The Covid-19 treatment candidate has been developed by immunising horses with spike glycoprotein of the inactivated Covid virus. Speaking on the commencement of the clinical trials, Siddharth Daga, the chief …

India Clinical Trials Covid Clinical Vins Bioproducts

3 years, 7 months ago

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

India TV News

Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday. The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius. "Now, we are herewith …

India Life Bharat Shelf Dcgi Bharat Biotech Shelf Life

3 years, 8 months ago

DCGI approves SEC's emergency use recommendation for Sputnik V vaccine

Firstpost

India has authorised emergency use of Russia’s Sputnik V Covid-19 vaccine, the health ministry said Tuesday, as infection rates soar to record highs and some major cities boost their hospital bed capacity. Prasad, the co-chair of pharmaceutical company Dr Reddy’s Laboratories, said his firm was “very pleased to obtain the emergency use authorisation”. In India’s financial and film capital Mumbai, …

India Russia Sec Vaccine Sputnik Emergency Use Sputnik V

3 years, 8 months ago

Johnson & Johnson in talks with DCGI for trial of single-dose vaccine

India Today

The US drugs and healthcare giant, Johnson & Johnson, is in talks with Drugs Controller General of India to begin a clinical trial of its single-dose Covid-19 vaccine in the country. The Covid-19 vaccine developed by Johnson & Johnson is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa. Quoting …

India Vaccine Dcgi Local Johnson

Filters

Articles for Dcgi, search results for developed

Eye drop not intended to replace reading glasses, ENTOD pharma clarifies after DCGI suspension

Drug Developed Using DRDO Technology for Radiological and Nuclear Emergencies Gets DCGI Nod

Critical drug used during nuclear emergencies developed on DRDO tech gets approval

Drug developed using DRDO technology gets DCGI approval

Explained: As India Unveils SII's CERVAVAC, Know How Cervical Cancer Vaccines Work

DCGI Grants Marketing Authorisation to SII's QHPV Vaccine Against Cervical Cancer

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI

DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group

Bharat Biotech's intranasal COVID booster dose gets DGCI nod for phase 3 trials

Bharat Biotech submits data to DCGI for Covaxin for children in 2-18 age group | Exclusive

Proposal to study mixing of Covaxin, Covishield approved by DCGI

Faster & Cheaper Algorithm-based Covid-19 Testing Tool Gets DCGI Nod, Here's How It Works

Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources

Zydus Cadila Seeks DCGI Nod for Human Clinical Trials of Antibodies Cocktail to Treat Covid-19

Patanjali had proposed anti-Covid-19 use of a cancer drug one year ago

DCGI approves anti-COVID drug developed by DRDO for emergency use

Anti-Covid drug developed by DRDO approved for emergency use

Hetero Biopharma Gets DCGI Expert Panel's Nod for Phase III Trials of Sputnik V

VINS Bioproducts receives DCGI approval to start clinical trials for its Covid-19 treatment candidate

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

DCGI approves SEC's emergency use recommendation for Sputnik V vaccine

Johnson & Johnson in talks with DCGI for trial of single-dose vaccine